Artery Roadshow Hall Episode 8 | Healthcare Special Session Recap
The eighth edition of VCBeat Roadshow Hall’s premium features has arrived as scheduled. In this roadshow, we will12Month21Future Healthcare in Beijing Jiuhua Villa100Qiangda Conference&A Review and Retrospective of the VCBeat Roadshow Hall Series [Healthcare Special Session]50Other investors same22A healthcare project’s lively exchange on “capital matchmaking and value realization” held during a cold winter day.
The investment commentary panel for this dedicated roadshow featured Ms. Yu Jurong, Investment Partner at Zero2IPO Capital/Zero2IPO Healthcare; Mr. Liu Dan, Executive Director at CDH Investments; Mr. Li Zhe, Founding Partner at Baichuanghui/Bilin Star; Mr. Zhang Peng, Managing Partner at GTJA Capital; Mr. Zhang Shaoyu, Managing Director at Jiuheng Ventures; Mr. Zhang Quanyuan, Founding Partner at Huatai Healthcare Fund; Mr. Rong Chunhui, Investment Director at Kaifeng Venture Capital; and Ms. Zheng Yanjun, Partner at KIP Capital.
(The image shows the panelists watching the project pitch.)
(The image shows the panelists asking questions about the roadshow projects.)
More than 40 investors, including Qiming Venture Partners, Panlin Capital, Fosun Pharma, Sinopharm Group, Dongying Financial, PICC Yuanwang Industrial Investment, JPU Industrial Investment, Baichuanghui, China Renaissance, JD Allianz, Xuzhou Industrial Fund, CCB Medical Growth Fund, Zhiyin Capital, Qiangyun Capital, Fanzhuo Capital, Financial Street Investment, Guiyang Xintian Pharmaceutical, Shenzhou Holdings Group, Shanghai Hongyuan Investment, Linear Capital, Bauhinia Incubator, and Weiming Capital, attended the interactive exchange as investment observers.
(The image shows an investment observer watching a project roadshow and taking notes)
(The photo shows investment observers communicating with the project leaders of the roadshow)
We extend our gratitude to the aforementioned capital firms and investors for their support of this roadshow and for their engaging investment Q&A sessions. Special thanks are due to Mr. Yan Jingjing, Founding Partner of Probes Capital, for serving as the master of ceremonies for the entire roadshow; and to Mr. Xu Hong, Vice President of Zero2IPO Healthcare, and Ms. Yu Jurong, Partner at Zero2IPO Healthcare, for providing roadshow training and sharing their financing expertise.
This week, we have distributed the roadshow project materials to investors attending the offline roadshow, as well as to those who registered but were unable to attend due to other commitments. Next week, we will conduct sequential dialogues and surveys with capital partners and investors. Based on their feedback on the roadshow projects, we will facilitate effective matchmaking between investors and fundraisers and provide follow-up services.
At this dedicated roadshow, 22 high-quality healthcare projects were selected and stood out:
From the perspective of medical sub-sectors, there were five projects each in device innovation, service innovation, and digital innovation; four projects in biopharmaceuticals; and three projects in private specialized medical clinics.
In terms of funding rounds, there is 1 angel-round project, 15 projects at the A-round stage (including Pre-A, A, and A+ rounds), 4 B-round projects, and 2 C-round projects;
In terms of financing amounts, there were 15 projects below RMB 50 million, 5 projects in the RMB 50–100 million range, and 2 projects above RMB 100 million (denominated in RMB).
Below is a review of the roadshows presented by 22 project teams, covering their investment highlights, core teams, business models, development plans, and fundraising strategies.
Investment institutions and project sponsors interested in the current roadshow projects, wishing to participate in VCBeat Roadshow Hall’s online promotions, or having suggestions for improving the content and format of the Roadshow Hall’s promotions are welcome to contact Xiao Yun, VCBeat’s financing assistant. See you at VCBeat Roadshow Hall in 2020.
